Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery

LAUSANNE, Switzerland, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, today announced that the first patient has been enrolled in its Phase 3 OPTIMIZE (Once-daily Post ocular surgery Treatment for InflaMmation and paIn to... » read more

Dora Factory HEXA IDO Launch
Dora Factory HEXA IDO Launch

Singapore, Mar 30, 2021 – (ACN Newswire via SEAPRWire.com) – Dora Factory (DORA) successfully completed its HEXA launch on the 21st and 22nd of March, completing its IDO, otherwise known as Initial DEX offering. The launch commenced on the 21st with DEX including DuckStarter, gate.io & MXC and continued the following day with Bounce and... » read more